Pulmatrix PULM 深 滬
等待開盤 09-17 09:30:00 美东时间
1.40
-0.045
-3.11%
華盛通- 最 高1.4401
- 今 開1.44
- 成交量 1.71万股
- 最 低 1.3824
- 昨 收 1.445
- 總市值 511.32万
- 52周最高 5.498
- 市盈率 靜 --
- 換手率 0.47%
- 52周最低 1.16
- 委 比 -44.86%
- 總股本 365.23万
- 歷史最高 4235.00
- 量 比 0.23
- 振 幅 3.99%
- 歷史最低 1.16
- 每 手 1
- 風險率 1.35%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Pulmatrix Q2 EPS $(0.29) Up From $(0.42) YoY
Pulmatrix (NASDAQ:PULM) reported quarterly losses of $(0.29) per share. This is a 30.95 percent increase over losses of $(0.42) per share from the same period last year.
08-13 20:52
Pulmatrix GAAP EPS of -$0.29
Pulmatrix press release (PULM): Q2 GAAP EPS of -$0.29. The Company's total cash and cash equivalents balance as of June 30, 2026, was $2.2 million, in addition to $0.7 million in restricted cash that ...
08-13 20:17
并购调查律所对PULM、SLP、OLN、HUN四起交易发起股东权益审查
并购集体诉讼律师事务所Monteverde & Associates PC宣布，正对四起上市公司并购交易发起股东权益调查，涉及Pulmatrix、...
07-11 03:53
Pulmatrix Q1 EPS $(0.32) Up From $(0.50) YoY
Pulmatrix (NASDAQ:PULM) reported quarterly losses of $(0.32) per share. This is a 36 percent increase over losses of $(0.50) per share from the same period last year.
05-15 20:23
Pulmatrix Signs Agreement To Acquire Eos SENOLYTIX; Financial Terms Undisclosed
Pulmatrix, Inc. (Nasdaq: PULM) ("Pulmatrix") and Eos SENOLYTIX, Inc. ("Eos"), a biotechnology company developing novel gerotherapeutic peptides targeting mitochondrial dysfunction in aging-related diseases, today jointly
03-26 20:03
Pulmatrix shares are trading lower after a planned acquisition was rejected.
Pulmatrix shares are trading lower after a planned acquisition was rejected.
03-03 03:48
Pulmatrix Q4 EPS $(0.25) Up From $(0.55) YoY
Pulmatrix (NASDAQ:PULM) reported quarterly losses of $(0.25) per share. This is a 54.55 percent increase over losses of $(0.55) per share from the same period last year.
02-26 21:19
